Recent Updates
-
Humira vs. Remicade vs. Enbrel: which TNF inhibitor is right for you?Humira (adalimumab) is the best‑selling drug in history — it's a subcutaneous injection every 2 weeks. Remicade (infliximab) is intravenous, given every 4‑8 weeks in a clinic. Enbrel (etanercept) is a fusion protein, injected weekly. The US tumor necrosis factor alpha inhibitors market research shows that monoclonal antibodies (Humira, Remicade) hold the largest share, but...0 Comments 0 Shares 120 Views 0 ReviewsPlease log in to like, share and comment!
-
Rheumatoid arthritis vs. psoriasis: two different TNF inhibitor marketsRheumatoid arthritis (RA) is the largest indication — it affects 1.3 million Americans, and TNF inhibitors are first‑line after methotrexate. Psoriasis is the fastest‑growing indication, driven by the approval of TNF inhibitors for psoriatic arthritis and plaque psoriasis. The TNF alpha inhibitors market research shows that psoriasis will grow at over 4% CAGR, faster than RA....0 Comments 0 Shares 121 Views 0 Reviews
-
Microwave vs. radiofrequency ablation: which one is better?Radiofrequency ablation (RFA) has been the workhorse for 20+ years — it's reliable, cheap, and well‑studied. Microwave ablation (MWA) is newer — it heats faster, creates larger ablation zones, and is less affected by tissue charring. The US tumor ablation market research shows that RFA holds the largest share, but MWA is the fastest‑growing, with a CAGR above 12%. Why...0 Comments 0 Shares 142 Views 0 Reviews
-
RF vs. microwave ablation: which heat technology wins?Radiofrequency (RF) ablation has been around for decades — it's reliable and well‑studied. Microwave ablation is newer — it heats faster, creates larger zones, and is less affected by blood flow (heat sink). The tumor ablation market research shows that RF holds the largest share, but microwave is the fastest‑growing, with a CAGR above 12%. Why the shift? Because...0 Comments 0 Shares 151 Views 0 Reviews
-
The lawnmower risk: why tularemia is a hazard for suburbanites tooYou don't have to be a hunter to get tularemia. In the US, a surprising number of cases come from mowing over a dead rabbit or rodent. The bacteria become aerosolized, and you inhale them. The US tularemia market research shows that pneumonic tularemia is the fastest‑growing infection type, with a CAGR above 5%. Why? Because suburban sprawl brings people into contact with wildlife....0 Comments 0 Shares 124 Views 0 Reviews
-
Serology vs. PCR: which tularemia test wins?Serology looks for antibodies — it's cheap and widely available, but antibodies take 1‑2 weeks to appear. PCR detects bacterial DNA — it's fast (hours) and specific, but requires a lab and trained staff. The tularemia market research shows that serological testing holds the largest share, but molecular diagnostics is the fastest‑growing, with a CAGR above 6%. Why the...0 Comments 0 Shares 143 Views 0 Reviews
-
Mental health telehealth: the fastest‑growing specialtyOne in five adults struggles with mental illness. But stigma and lack of access keep many from seeking help. Online therapy is changing that. The online doctor consultation market research shows that mental health is the fastest‑growing specialty, with a CAGR above 16%. Why the surge? Because people are more comfortable talking to a therapist from home, and insurance coverage has...0 Comments 0 Shares 108 Views 0 Reviews
-
Antihistamine vs. steroid nasal sprays: which one should you use?Antihistamine sprays (azelastine) block histamine, providing rapid relief from sneezing and itching. Steroid sprays reduce inflammation, helping with congestion and post‑nasal drip. The nasal spray market research shows that antihistamines hold a large share, but nasal steroids are the fastest‑growing therapeutic class, with a CAGR above 8%. Why the surge? Because combination sprays...0 Comments 0 Shares 113 Views 0 Reviews
-
Nanosensors vs. nano implants: which one is the future of diagnostics?Nanosensors are tiny devices that detect chemicals, proteins, or DNA — they're used in lab‑on‑a‑chip diagnostics. Nano implants are devices placed inside the body to monitor or treat — like glucose sensors or drug‑eluting stents. The nano healthcare technology market research shows that nanosensors hold the largest share, but nano implants are the fastest‑growing, with a...0 Comments 0 Shares 148 Views 0 Reviews
-
GLP‑1 agonists: miracle drugs for metabolic syndrome, but who can afford them?Ozempic, Wegovy, Mounjaro — you've heard the hype. These GLP‑1 agonists were diabetes drugs, but they cause dramatic weight loss and improve every component of metabolic syndrome. The metabolic syndrome market research study shows that the pharmaceutical segment is the largest by far, driven by these blockbusters. But here's the rub: they cost $1,000+ per month, and many...0 Comments 0 Shares 151 Views 0 Reviews
-
Reusable vs. disposable menstrual cups: which one wins?Reusable cups are the classic — you wash them, boil them, and use them for years. Disposable cups are newer — use once, throw away. The menstrual cup market research shows that reusable cups hold the largest share, but disposable cups are the fastest‑growing. Why? Because some women want the convenience of disposables without the environmental guilt of pads and tampons....0 Comments 0 Shares 126 Views 0 Reviews
-
Telemedicine second opinions: the fastest‑growing serviceHospitals and in‑person consultations have been the traditional way — you travel to a specialist, wait weeks, and pay a high fee. But telemedicine is the fastest‑growing service type. The medical second opinion market research shows that virtual consultations are growing at over 15% CAGR, driven by smartphone penetration and a younger, tech‑savvy population. Patients upload...0 Comments 0 Shares 120 Views 0 Reviews
More Stories